TRIMEDYNE REPORTS A 33% INCREASE IN REVENUES
IN THE QUARTER ENDED DEC. 31, 2004
15, 2005 – Irvine, CA: TRIMEDYNE, INC. (OTCBB “TMED”)
today reported a 33% increase in revenues to $1,839,000 for the
quarter ended December 31, 2004, compared to revenues of $
1,380,000 for the same quarter of the prior year.
profit was $173,000 or $0.01 per share for the current quarter,
compared to a net profit of $165,000 or $0.01 per share in the
prior year quarter. However,
the profit for the prior year quarter included the benefit of
$123,000 of other income, whereas other income in the current
quarter was only $26,000, and R & D costs in the current
quarter were twice those of the year earlier quarter, $133,000
D. Yeik, President of Trimedyne, said, “We are pleased to
report a significant increase in sales of our surgical lasers in
the current quarter, compared to the year ago period. While marketing expenses to introduce our new disposable
devices are expected to rise in the coming months, we anticipate
our revenues will increase from sales of the new products,
although such cannot be assured.”
Trimedyne manufactures lasers and proprietary
fiber optic devices for a variety of minimally invasive surgical
procedures, many of which are performed on an outpatient basis
at substantially less cost than conventional surgery.
For product, financial and other information, visit
Trimedyne's website http://www.trimedyne.com.
"Safe Harbor" Statement
Under the Private Securities Litigation Reform Act:
Statements in this news release may contain
forward-looking statements within the meaning of Section 27A of
the U.S. Securities Act of 1993 and Section 21E of the
Securities and Exchange Act of 1934.
Such statements may involve various risks and
uncertainties, some of which may be discussed in the Company's
most recent report on Form 10-KSB and subsequently filed SEC
reports. There is
no assurance any new products can be cleared for sale by the FDA
or successfully commercialized or any forward-looking statements
will prove accurate, as actual results and future events could
differ materially from those presently anticipated.